JP2023552329A5 - - Google Patents
Info
- Publication number
- JP2023552329A5 JP2023552329A5 JP2023532489A JP2023532489A JP2023552329A5 JP 2023552329 A5 JP2023552329 A5 JP 2023552329A5 JP 2023532489 A JP2023532489 A JP 2023532489A JP 2023532489 A JP2023532489 A JP 2023532489A JP 2023552329 A5 JP2023552329 A5 JP 2023552329A5
- Authority
- JP
- Japan
- Prior art keywords
- suspension
- approximately
- dose
- paliperidone
- palmitate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025173295A JP2026027255A (ja) | 2020-11-30 | 2025-10-15 | 持続放出パリペリドン注射可能製剤に関連する投与レジメン |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063119405P | 2020-11-30 | 2020-11-30 | |
| US63/119,405 | 2020-11-30 | ||
| PCT/EP2021/062147 WO2022111859A1 (en) | 2020-11-30 | 2021-05-07 | Dosing regimens associated with extended release paliperidone injectable formulations |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025173295A Division JP2026027255A (ja) | 2020-11-30 | 2025-10-15 | 持続放出パリペリドン注射可能製剤に関連する投与レジメン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023552329A JP2023552329A (ja) | 2023-12-15 |
| JP2023552329A5 true JP2023552329A5 (https=) | 2024-05-17 |
| JP7792959B2 JP7792959B2 (ja) | 2025-12-26 |
Family
ID=75888043
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023532489A Active JP7792959B2 (ja) | 2020-11-30 | 2021-05-07 | 持続放出パリペリドン注射可能製剤に関連する投与レジメン |
| JP2025173295A Pending JP2026027255A (ja) | 2020-11-30 | 2025-10-15 | 持続放出パリペリドン注射可能製剤に関連する投与レジメン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025173295A Pending JP2026027255A (ja) | 2020-11-30 | 2025-10-15 | 持続放出パリペリドン注射可能製剤に関連する投与レジメン |
Country Status (22)
| Country | Link |
|---|---|
| US (3) | US11304951B1 (https=) |
| EP (2) | EP4025188B1 (https=) |
| JP (2) | JP7792959B2 (https=) |
| KR (2) | KR102794804B1 (https=) |
| CN (1) | CN116583270A (https=) |
| AU (2) | AU2021386450B2 (https=) |
| CA (1) | CA3203566A1 (https=) |
| DK (1) | DK4025188T3 (https=) |
| ES (1) | ES2973583T3 (https=) |
| FI (1) | FI4025188T3 (https=) |
| HR (1) | HRP20240074T1 (https=) |
| HU (1) | HUE065573T2 (https=) |
| IL (1) | IL303253A (https=) |
| LT (1) | LT4025188T (https=) |
| MX (2) | MX2023006366A (https=) |
| PL (1) | PL4025188T3 (https=) |
| PT (1) | PT4025188T (https=) |
| RS (1) | RS65178B1 (https=) |
| SI (1) | SI4025188T1 (https=) |
| SM (1) | SMT202400077T1 (https=) |
| TW (2) | TWI877363B (https=) |
| WO (1) | WO2022111859A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7839162B2 (ja) | 2020-11-30 | 2026-04-01 | ヤンセン ファーマシューティカ エヌ．ベー． | パルミチン酸パリペリドン製剤の再懸濁を確実にする方法 |
| KR102794804B1 (ko) * | 2020-11-30 | 2025-04-10 | 얀센 파마슈티카 엔브이 | 서방형 팔리페리돈 주사용 제형과 관련된 투약 요법 |
| ES2981035T3 (es) | 2020-11-30 | 2024-10-07 | Janssen Pharmaceutica Nv | Regímenes de dosificación asociados con formulaciones inyectables de paliperidona de liberación prolongada |
| MX2023006370A (es) | 2020-11-30 | 2023-08-07 | Janssen Pharmaceutica Nv | Regimenes de dosificacion asociados con formulaciones inyectables de paliperidona de liberacion prolongada. |
| MX2024002215A (es) | 2021-08-20 | 2024-05-10 | Janssen Pharmaceutica Nv | Regímenes de dosificación asociados con formulaciones inyectables de paliperidona de liberación prolongada. |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5254556A (en) | 1988-11-07 | 1993-10-19 | Janssen Pharmaceutica N.V. | 3-piperidinyl-1,2-benzisoxazoles |
| US5158952A (en) | 1988-11-07 | 1992-10-27 | Janssen Pharmaceutica N.V. | 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use |
| TW487572B (en) | 1996-05-20 | 2002-05-21 | Janssen Pharmaceutica Nv | Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters |
| UA72189C2 (uk) | 1997-11-17 | 2005-02-15 | Янссен Фармацевтика Н.В. | Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот |
| WO2006114384A1 (en) | 2005-04-25 | 2006-11-02 | Janssen Pharmaceutica N.V. | Preparation of aseptic 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4h-pyridio[1,2-a]pyrimidin-4-one palmitate ester |
| KR102318070B1 (ko) * | 2007-12-19 | 2021-10-27 | 얀센 파마슈티카 엔.브이. | 장기 작용성 주사가능 팔리페리돈 에스테르와 관련된 투여 요법 |
| WO2011042453A1 (en) | 2009-10-06 | 2011-04-14 | Ascendis Pharma As | Subcutaneous paliperidone composition |
| BR112012010195A2 (pt) | 2009-10-30 | 2016-04-26 | Janssen Pharmaceutica Nv | regime de dosagem associado a ésteres de paliperidona injetável de longa ação |
| ES2456917T3 (es) | 2011-05-31 | 2014-04-24 | Laboratorios Farmacéuticos Rovi, S.A. | Formulación de implante de paliperidona |
| WO2016157061A1 (en) * | 2015-03-31 | 2016-10-06 | Wockhardt Limited | Aseptic wet milling process for paliperidone palmitate |
| RS65024B1 (sr) * | 2015-04-07 | 2024-01-31 | Janssen Pharmaceutica Nv | Dozni režim za propuštene doze injektibilnih estara paliperidona sa produženim delovanjem |
| HK1254640A1 (zh) * | 2015-06-19 | 2019-07-26 | Janssen Pharmaceutica, N.V. | 用於药物施用和混合的设备和方法及用於所述设备和方法的适当技术的训练 |
| PL3723760T3 (pl) * | 2017-12-14 | 2025-10-20 | SpecGx LLC | Jednoetapowy sposób mielenia w celu wytworzenia zmikronizowanych estrów paliperydonu |
| KR102794804B1 (ko) * | 2020-11-30 | 2025-04-10 | 얀센 파마슈티카 엔브이 | 서방형 팔리페리돈 주사용 제형과 관련된 투약 요법 |
-
2021
- 2021-05-07 KR KR1020237021429A patent/KR102794804B1/ko active Active
- 2021-05-07 RS RS20240116A patent/RS65178B1/sr unknown
- 2021-05-07 TW TW110116515A patent/TWI877363B/zh active
- 2021-05-07 DK DK21724652.9T patent/DK4025188T3/da active
- 2021-05-07 PL PL21724652.9T patent/PL4025188T3/pl unknown
- 2021-05-07 FI FIEP21724652.9T patent/FI4025188T3/fi active
- 2021-05-07 WO PCT/EP2021/062147 patent/WO2022111859A1/en not_active Ceased
- 2021-05-07 LT LTEPPCT/EP2021/062147T patent/LT4025188T/lt unknown
- 2021-05-07 ES ES21724652T patent/ES2973583T3/es active Active
- 2021-05-07 SM SM20240077T patent/SMT202400077T1/it unknown
- 2021-05-07 EP EP21724652.9A patent/EP4025188B1/en active Active
- 2021-05-07 JP JP2023532489A patent/JP7792959B2/ja active Active
- 2021-05-07 CN CN202180080433.0A patent/CN116583270A/zh active Pending
- 2021-05-07 EP EP23219765.7A patent/EP4356966A3/en active Pending
- 2021-05-07 IL IL303253A patent/IL303253A/en unknown
- 2021-05-07 MX MX2023006366A patent/MX2023006366A/es unknown
- 2021-05-07 AU AU2021386450A patent/AU2021386450B2/en active Active
- 2021-05-07 HU HUE21724652A patent/HUE065573T2/hu unknown
- 2021-05-07 CA CA3203566A patent/CA3203566A1/en active Pending
- 2021-05-07 US US17/314,330 patent/US11304951B1/en active Active
- 2021-05-07 TW TW114105894A patent/TW202539685A/zh unknown
- 2021-05-07 HR HRP20240074TT patent/HRP20240074T1/hr unknown
- 2021-05-07 KR KR1020257011387A patent/KR20250053980A/ko active Pending
- 2021-05-07 PT PT217246529T patent/PT4025188T/pt unknown
- 2021-05-07 SI SI202130102T patent/SI4025188T1/sl unknown
-
2022
- 2022-04-13 US US17/719,686 patent/US20220249495A1/en not_active Abandoned
-
2023
- 2023-05-30 MX MX2024009188A patent/MX2024009188A/es unknown
-
2024
- 2024-06-20 AU AU2024204213A patent/AU2024204213B2/en active Active
-
2025
- 2025-08-06 US US19/291,832 patent/US20260060986A1/en active Pending
- 2025-10-15 JP JP2025173295A patent/JP2026027255A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023552329A5 (https=) | ||
| JP2023552149A5 (https=) | ||
| JP3701870B2 (ja) | 末梢血管疾患治療のための９−デオキシ−２’，９−α−メタノ−３−オキサ−４，５，６−トリノール−３，７−（１’，３’−インターフェニ | |
| JP2023551009A5 (https=) | ||
| JP2022539821A5 (https=) | ||
| JPH10511075A (ja) | 骨格筋収縮を阻害する酸化窒素種および付加物の使用 | |
| JP2023535744A5 (https=) | ||
| FI4025188T3 (fi) | Pitkävaikutteisiin injektoitaviin paliperidoniformulaatioihin liittyviä annosteluohjelmia | |
| JP2022526763A5 (https=) | ||
| AU618997B2 (en) | Pharmaceutical compositions with anti-cancer activity and method for the treatment of cancer | |
| FI4025189T3 (fi) | Viivästetysti vapauttavaan injektoitavaan paliperidoniin liittyviä annostusohjelmia | |
| JPS59193821A (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
| FI4025187T3 (fi) | Pitkävaikutteisiin injektoitaviin paliperidoniformulaatioihin liittyviä annosteluohjelmia | |
| EP2116241B1 (en) | Pharmaceutical composition | |
| JP2022535920A5 (https=) | ||
| EA004474B1 (ru) | Комбинированное лечение заболевания цнс, особенно болезни паркинсона, путём совместного введения каберголина и прамипексола | |
| US20230181704A1 (en) | Anti-sars-cov-2 virus agent antiprovir | |
| MX2021008208A (es) | Tesofensina para la reduccion del peso corporal para pacientes con sindrome de prader-willi. | |
| JP2023543439A5 (https=) | ||
| CN111166898B (zh) | 锝[99Tc]唑来膦酸在制备治疗骨质疏松药物中的应用 | |
| TWI289060B (en) | Pharmaceutical composition for improving the recovery of post-stroke patients | |
| JP2022538898A5 (https=) | ||
| KR20210137484A (ko) | 캡시드 조립 조절제 고체 제형 | |
| US11452710B1 (en) | Micronutrient and plant extract composition and method of improving bone health | |
| JP2627914B2 (ja) | プロスタグランジン類の選択的作用増強剤 |